EP4082579 - POLYNUCLEOTIDE AND MEDICINAL COMPOSITION [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 30.09.2022 Database last updated on 21.03.2025 | |
Former | The international publication has been made Status updated on 07.07.2021 | Most recent event Tooltip | 23.12.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states National University Corporation Tokai National Higher Education and Research System 1, Furo-cho Chikusa-ku Nagoya-shi, Aichi 464-8601 / JP | For all designated states Kyowa Kirin Co., Ltd. 1-9-2, Otemachi Chiyoda-ku Tokyo 100-0004 / JP | [2022/44] | Inventor(s) | 01 /
ABE, Hiroshi c/o National University Corporation Tokai National Higher Education and Research System, 1 Furo-cho, Chikusa-ku Nagoya-shi, Aichi 464-8601 / JP | 02 /
IWAI, Hiroto c/o Head Office, Kyowa Kirin Co., Ltd., 1-9-2, Otemachi, Chiyoda-ku Tokyo 100-0004 / JP | 03 /
HOMMA, Masakazu c/o Head Office, Kyowa Kirin Co., Ltd., 1-9-2, Otemachi, Chiyoda-ku Tokyo 100-0004 / JP | 04 /
ASANO, Kana c/o Head Office, Kyowa Kirin Co., Ltd., 1-9-2, Otemachi, Chiyoda-ku Tokyo 100-0004 / JP | 05 /
HARADA, Kenji c/o Head Office, Kyowa Kirin Co., Ltd., 1-9-2, Otemachi, Chiyoda-ku Tokyo 100-0004 / JP | 06 /
YAMAMOTO, Junichiro c/o Head Office, Kyowa Kirin Co., Ltd., 1-9-2, Otemachi, Chiyoda-ku Tokyo 100-0004 / JP | 07 /
SHINOHARA, Fumikazu c/o Head Office, Kyowa Kirin Co., Ltd., 1-9-2, Otemachi, Chiyoda-ku Tokyo 100-0004 / JP | 08 /
MOTOSAWA, Keiichi c/o Head Office, Kyowa Kirin Co., Ltd., 1-9-2, Otemachi, Chiyoda-ku Tokyo 100-0004 / JP | 09 /
KIMURA, Yasuaki c/o National University Corporation Tokai National Higher Education and Research System, 1 Furo-cho, Chikusa-ku Nagoya-shi, Aichi 464-8601 / JP | 10 /
NAKAMOTO, Kosuke c/o National University Corporation Tokai National Higher Education and Research System, 1 Furo-cho, Chikusa-ku Nagoya-shi, Aichi 464-8601 / JP | [2022/44] | Representative(s) | D Young & Co LLP 3 Noble Street London EC2V 7BQ / GB | [N/P] |
Former [2022/44] | D Young & Co LLP 120 Holborn London EC1N 2DY / GB | Application number, filing date | 20906594.5 | 25.12.2020 | [2022/44] | WO2020JP48799 | Priority number, date | JP20190236399 | 26.12.2019 Original published format: JP 2019236399 | [2022/44] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021132589 | Date: | 01.07.2021 | Language: | JA | [2021/26] | Type: | A1 Application with search report | No.: | EP4082579 | Date: | 02.11.2022 | Language: | EN | [2022/44] | Search report(s) | International search report - published on: | JP | 01.07.2021 | (Supplementary) European search report - dispatched on: | EP | 27.05.2024 | Classification | IPC: | A61K48/00, A61P43/00, C07H21/02, C12N15/10, C12N15/11 | [2022/44] | CPC: |
A61P43/00 (EP,KR);
C12N15/11 (KR,US);
A61K48/00 (KR);
C07H19/16 (EP);
C07H21/02 (EP,KR);
C12N15/10 (KR);
C12N15/67 (EP);
C12N2310/315 (KR,US);
C12N2310/32 (KR,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/44] | Title | German: | POLYNUKLEOTID UND MEDIZINISCHE ZUSAMMENSETZUNG | [2022/44] | English: | POLYNUCLEOTIDE AND MEDICINAL COMPOSITION | [2022/44] | French: | POLYNUCLÉOTIDE ET COMPOSITION MÉDICINALE | [2022/44] | Entry into regional phase | 25.07.2022 | Translation filed | 25.07.2022 | National basic fee paid | 25.07.2022 | Search fee paid | 25.07.2022 | Designation fee(s) paid | 25.07.2022 | Examination fee paid | Examination procedure | 25.07.2022 | Examination requested [2022/44] | 12.12.2024 | Amendment by applicant (claims and/or description) | 12.12.2024 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 13.12.2022 | Renewal fee patent year 03 | 14.12.2023 | Renewal fee patent year 04 | 23.12.2024 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | by applicant | WO2014093574 | WO2017123669 |